Will Mattress Firm (MFRM) Stock Be Helped Today by Earnings Results?

NEW YORK (TheStreet) -- Mattress Firm Holding Corp. (MFRM)  released its third quarter earnings results after the market closed on Monday. The stock was up over 3% in after-hours trading before falling back down by 0.89% to $69 in after-hours trading. 

For the most recent quarter the specialty retailer of mattresses and related products said adjusted net income per share was 70 cents, which was in-line with analysts' estimates for the quarter.

Mattress Firm said revenue for the 2014 third quarter grew by 42.3% to $464.3 million, when compared with the same period in 2013.STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The company's net sales beat the $431 million analysts had expected Mattress Firm to post this quarter.

Mattress Firm's comparable store sales grew by 8.5% for the latest quarter.

Separately, TheStreet Ratings team rates MATTRESS FIRM HOLDING CORP as a Buy with a ratings score of A-. TheStreet Ratings Team has this to say about their recommendation:

"We rate MATTRESS FIRM HOLDING CORP (MFRM) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity."

You can view the full analysis from the report here: MFRM Ratings Report

MFRM Chart MFRM data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing